Who owns Ovid Therapeutics Inc.?
Institutional ownership of OVID from SEC Form 13F filings across 88 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
88
13F holders
$215.8M
value, 2026 filers
43.1%
of shares outstanding (80.4M sh)
31
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of OVID's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Jupiter Topco LLCNEW | 20.7M | $55.9M | 0.0% | 11.1% | new |
| 2 | BlackRock, Inc. | 10.8M | $29.1M | 0.0% | 5.8% | +605.9% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 7.8M | $20.9M | 0.0% | 4.2% | -26.2% |
| 4 | Balyasny Asset Management L.P. | 6.7M | $18.1M | 0.0% | 3.6% | +21.4% |
| 5 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 6.2M | $16.6M | 0.0% | 3.3% | 0.0% |
| 6 | FEDERATED HERMES, INC. | 6.0M | $16.0M | 0.0% | 3.2% | +66.7% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 4.1M | $11.0M | 0.0% | 2.2% | +209.0% |
| 8 | SILVERARC CAPITAL MANAGEMENT, LLC | 3.1M | $8.3M | 0.9% | 1.7% | +210.1% |
| 9 | Point72 Asset Management, L.P. | 1.9M | $5.2M | 0.0% | 1% | +47.3% |
| 10 | NORTHERN TRUST CORP | 1.2M | $3.4M | 0.0% | 0.7% | +389.1% |
| 11 | VANGUARD FIDUCIARY TRUST CO | 1.1M | $3.1M | 0.0% | 0.6% | +64.6% |
| 12 | VANGUARD PORTFOLIO MANAGEMENT LLCNEW | 1.0M | $2.8M | 0.0% | 0.6% | new |
| 13 | Sio Capital Management, LLC | 1.0M | $2.7M | 0.4% | 0.5% | -19.7% |
| 14 | Nuveen, LLCNEW | 893,254 | $2.4M | 0.0% | 0.5% | new |
| 15 | TWO SIGMA INVESTMENTS, LP | 832,378 | $2.2M | 0.0% | 0.4% | -33.8% |
| 16 | WELLS FARGO & COMPANY/MN | 826,206 | $2.2M | 0.0% | 0.4% | +15.8% |
| 17 | BOOTHBAY FUND MANAGEMENT, LLC | 737,758 | $2.0M | 0.0% | 0.4% | -20.5% |
| 18 | UBS Group AG | 458,917 | $1.2M | 0.0% | 0.2% | +65.3% |
| 19 | Sixth Street Partners Management Company, L.P.NEW | 444,042 | $1.2M | 0.2% | 0.2% | new |
| 20 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 444,042 | $1.2M | 0.0% | 0.2% | +516.7% |
| 21 | Bank of New York Mellon Corp | 416,318 | $1.1M | 0.0% | 0.2% | +656.4% |
| 22 | BANK OF AMERICA CORP /DE/ | 409,490 | $1.1M | 0.0% | 0.2% | +41.0% |
| 23 | GOLDMAN SACHS GROUP INC | 332,692 | $894,942 | 0.0% | 0.2% | +117.7% |
| 24 | CIBC WORLD MARKET INC. | 218,851 | $588,709 | 0.0% | 0.1% | -12.2% |
| 25 | SEI INVESTMENTS CO | 196,685 | $529,083 | 0.0% | 0.1% | -40.2% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.